Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis

European Journal of Endocrinology

Volumn 156, Issue 4, 2007, Pages 431-437

  Antonelli, Alessandro ^a   Ferri, Clodoveo ^b   Fallahi, Poupak ^a   Cazzato, Massimiliano ^a   Ferrari, Silvia Martina ^a   Sebastiani, Marco ^b   Ferrannini, Ele ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; AUTOIMMUNE THYROIDITIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SYSTEMIC SCLEROSIS; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CARCINOMA, PAPILLARY; FEMALE; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; MIDDLE AGED; PREVALENCE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; THYROID DISEASES; THYROID NEOPLASMS; THYROTROPIN;

EID: 34247577992     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-06-0591     Document Type: Article

References (46)

1. Medsger TA Jr. Systemic sclerosis (scleroderma): clinical aspects. in Arthritis and Allied Conditions, edn 14, pp 1590-1624. Ed. WJ Koopman, Philadelphia: Lippincott Williams & Wilkins, 2001.
2. Black CM & Denton CP. Scleroderma and related disorders in adults and children. In Oxford Textbook of Rheumatology, edn 3, pp 872-895. EdsDA Isenberg, PJ Maddison, P Woo, D Glass & FC Breedveld, Oxford: Oxford Writing Press, 2004.
3. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F, Giuggioli D, Cuomo G, Rosada M, Bombardieri S, Todesco S & Tirri G. Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic Sclerosis: demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine 2002 8 139-153.
4. Ferri C, Giuggioli D, Sebastiani M, Colaci M & Emdin M. Heart involvement and systemic sclerosis. Lupus 2005 14 702-707.
5. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Commitee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis and Rheumatism 1980 23 581-590.
6. Rocco VK & Hurd ER. Scleroderma and scleroderma-like disorders. Seminars in Arthritis and Rheumatism 1986 16 22-69.
7. D'Angelo WA, Fries JF, Masi AT & Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. American Journal of Medicine 1969 46 428-440.
8. Gordon MB, Klein I, Dekker A, Rodnan GP & Medsger TA Jr. Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Annals of Internal Medicine 1981 95 431-435.
9. Schwarz W, Schell H & Hornstein OP. Serum levels of thyreotropin in progressive scleroderma. Archives of Dermatological Research 1981 271 451-453.
10. Serup J & Hangdrup H. Thyroid hormones in generalized scleroderma. A controlled study. Acta Dermato Venereologica 1986 66 35-38.
11. Kahl LE, Medsger TA Jr & Klein I. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). Journal of Rheumatology 1986 13 103-107.
12. De Keyser L, Narhi DC, Furst DE, Huberman AK, Ross R, Clements J & Van Herle AJ. Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. Journal of Endocrinological Investigation 1990 13 161-169.
13. Molnar I, Balazs C, Szabo E & Czirjak L. Anti-thyroid antibodies and hypothyroidism in systemic sclerosis. Journal of Endocrinological Investigation 1992 15 311.
14. Molteni M, Barili M, Eisera. N, Scrofani S, Mascagni B, Zulian C & Scorza R. Anti-thyroid antibodies in Italian scleroderma patients: association of anti-thyroid peroxidase (anti-TPO) antibodies with HLA-DR15. Clinical and Experimental Rheumatology 1997 15 529-534.
15. Innocencio RM, Romaldini JH & Ward LS. Thyroid autoantibodies in autoimmune diseases. Medicina 2004 64 227-230.
16. Anderson JR, Goudie RB, Gray KG & Buchanan WW. Antibody to thyroglobulin in patients with collagen diseases. Scottish Medical Journal 1961 6 449-456.
17. Becker KL, Ferguson RH & McConahey WM. The connective-tissue diseases and symptoms associated with Hashimoto's thyroiditis. New England Journal of Medicine 1963 268 277-280.
18. Akikusa B, Kondo Y, Iemoto Y, Iesato K & Wakashin M. Hashimoto's thyroiditis and membranous nephropathy developed in progressive systemic sclerosis (PSS). American Journal of Clinical Pathology 1984 81 260-263.
19. Mulhern LM, Masi AT & Shulman LE. Hashimoto's disease. A search for associated disorders in 170 clinically detected cases. Lancet 1966 2 508-511.
20. Shoaleh-var M, Momtaz AH & Jamshidi C. Scleroderma and hyperthyroidism. Report of a case. JAMA 1976 235 752-753.
21. Ward JA, Mendeloff J & Coberly JC. Hyperthyroidism followed by scleroderma. JAMA 1977 237 1123.
22. Nicholson D, White S. Lipson A, Jacobs RP & Borenstein DG. Progressive systemic sclerosis and Graves' disease. Report of three cases. Archives of Internal Medicine 1986 146 2350-2352.
23. Kucharz EJ. Thyroid disorders in patients with prosgressive systemic sclerosis: a review. Clinical Rheumatology 1993 12 159-161.
24. Molnar I & Czirjak L. Euthyroid sick syndrome and inhibitory effect of sera on the activity of thyroid 5′-deiodinase in systemic sclerosis. Clinical and Experimental Rheumatology 2000 18 719-724.
25. Mourier-Clavreul MC, Rousset H & Claudy A. Scleroderma and thyroid diseases. Annales de Dermatologie et de Venereologie 1989 116 701-706.
26. Medsger TA Jr. Systemic sclerosis and malignancy-are they related? Journal of Rheumatology 1985 12 1041-1043.
27. Donati L, Antonelli A, Bertoni F, Moscogiuri D, Andreani M, Venturi S, Filippi T, Gasperini L, Neri S & Baschieri L. Clinical picture of endemic cretinism in central Appennines (Montefeltro). Thyroid 1992 2 283-290.
28. Antonelli A, Ferri C & Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA 1999 281 1588.
29. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, Marchi S & Ferrannini E. Thyroid disorders in chronic hepatitis C. American Journal of Medicine 2004 117 10-13.
30. Antonelli A, Fallahi P, Nesti C, Pupilli C, Marchetti P, Takasawa S, Okamoto H & Ferrannini E. Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clinical and Experimental Immunology 2001 126 426-431.
31. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Paolicchi A, Ferrannini E & Serio M. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. European Journal of Endocrinology 2005 152 171-177.
32. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E & Serio M. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2004 89 5496-5499.
33. Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C, Pinchera A & Martino E. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. Journal of Endocrinological Investigation 1995 18 857-861.
34. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A & Pinchera A. The spectrum of thyroid disorders in a iodine-deficient community: the Pescopagano survey. Journal of Clinical Endocrinology and Metabolism 1999 84 561-566.
35. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T & Smith PA. The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology 1977 7 481-493.
36. Vanderpump MP & Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002 12 839-847.
37. Antonelli A, Fazzi P, Fallahi P, Ferrari SM & Ferrannini E. Prevalence of hypothyroidism and Graves disease in sarcoidosis. Chest 2006 130 526-532.
38. Antonelli A, Sedie AD, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, Bombardieri S & Riente L. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. Journal of Rheumatology 2006 033 2026-2028.
39. Romagnani S. The Th1/Th2 Paradigm in Disease New York: R.G. Landes Company, Austin/Springer-Verlag, 1997.
40. Romagnani S. The Th1/Th2 Paradigm. Immunology Today 1997 18 263-266.
41. Antonelli A, Rotondi M, Ferrari SM, Fallahi P, Romagnani P, Franceschini SS, Serio M & Ferrannini E. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. Journal of Clinical Endocrinology and Metabolism 2006 91 614-620.
42. Valentini G, Baroni A, Esposito K, Naclerio C, Buommino E, Farzati A, Cuomo G & Farzati B. Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. Journal of Clinical Immunology 2001 21 210-217.
43. Fujii H, Shimada Y, Hasegawa M, Takehara K & Sato S, Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. Journal of Dermatological Science 2004 35 43-51.
44. Lateiwish AM, Feher J, Baraczka K, Racz K, Kiss R & Glaz E. Remission of Raynaud's phenomenon after L-thyroxine therapy in a patient with hypothyroidism. Journal of Endocrinological Investigation 1992 15 49-51.
45. Shagan BP & Friedman SA. Raynaud's phenomenon and thyroid deficiency. Archives of Internal Medicine 1980 140 832-833.
46. Curnock AL, Dweik RA, Higgins BH, Saadi HF & Arroglia AC. High prevalence of hypothyroidism in patients with primary pulmonary hypertension. American Journal of the Medical Sciences 1999 318 289-292.